Open AccessUpdate on Hypertension and Adaptations for Treatment
Author(s) -
Divya Birudaraju,
Lavanya Cherukuri,
Matthew J. Budoff
Publication year - 2020
Publication title -
medical journal of southern california clinicians
Language(s) - English
Resource type - Journals
eISSN - 2576-1897
pISSN - 2576-1889
DOI - 10.38206/130103
Subject(s) - medicine , dash , overweight , blood pressure , myocardial infarction , stroke (engine) , weight loss , disease , dash diet , population , diabetes mellitus , obesity , cardiology , endocrinology , environmental health , mechanical engineering , computer science , engineering , operating system
Hypertension (HTN) affects 46% of the US adult population and plays a major role in cardiovascular disease (CVD). Approximately, there were 90,098 deaths in 2017 primarily attributed to high blood pressure (BP). Recent guidelines recommend screening all adults for HTN. Management of elevated BP substantially reduces the risk of heart failure, stroke, and myocardial infarction. Recommended lifestyle modifications include weight loss for overweight or obese patients, regular exercise, the dietary approached to stop hypertension (DASH) diet, reduced dietary sodium intake, and reduced alcohol intake. Most HTN patients will need at least 2 drugs to control BP. Current guidelines from the ACC and AHA state that a BP level goal of < 130/80mmHg for adults with confirmed HTN and without additional markers of increased atherosclerotic cardiovascular disease (ASCVD) risk may be acceptable.